. In situ adenoid cystic carcinoma (arrows) partially involving a duct (A; hematoxylin and eosin) associated with a primary adenoid cystic carcinoma of the breast (upper part of the micrograph). The partially involved duct contained nonneoplastic CK7positive luminal cells (B), some of which were estrogen receptor-positive (C), and an in situ adenoid cystic carcinoma displaying MYB (D) and p63 (E) co-expression. The intact layer of myoepithelial cells surrounding the duct was highlighted by expression of p63 (E) and calponin (F). While p63 was also expressed in the in situ and invasive adenoid cystic carcinoma cells (E), c-KIT expression was observed in both the normal breast luminal epithelial cells and cells surrounding the pseudo-cystic structures of the in situ and invasive adenoid cystic carcinoma (G).
has been described in the breast; however, its identification is not trivial. 3 Here, we illustrate an in situ adenoid cystic carcinoma partially involving a mammary duct in a 68-year-old woman with primary adenoid cystic carcinoma of the right breast. The double population of cells composing this intraductal lesion can be appreciated by its immunohistochemical profile (Figure 1) . Given that the neoplastic cells of the in situ lesion already express MYB, our findings are consistent with the notion that MYB overexpression is an early event in the tumorigenesis of adenoid cystic carcinomas. 4, 5 
